Healthcare -
Biotechnology - NASDAQ - US
$ 129.12
1.24 %
$ 6.3 B
Market Cap
-21.52
P/E
AXSM - STOCK-BASED COMPENSATION
Stock-based Compensation AXSM - Axsome Therapeutics, Inc.
85.2 M
LAST VALUE
50.30%
2 YEAR CAGR
69.37%
5 YEAR CAGR
71.97%
10 YEAR CAGR